Cargando…
Genetic variants of DNA repair genes predict the survival of patients with esophageal squamous cell cancer receiving platinum-based adjuvant chemotherapy
BACKGROUND: Adjuvant chemotherapy in patients with resected esophageal squamous cell cancer (ESCC) remains controversial for its uncertain role in improving overall survival (OS). Nucleotide excision repair (NER) removes DNA-adducts in tumor cells induced by the platinum-based chemotherapy and thus...
Autores principales: | Zhou, Fei, Zhu, Meiling, Wang, Mengyun, Qiu, Lixin, Cheng, Lei, Jia, Ming, Xiang, Jiaqing, Wei, Qingyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888614/ https://www.ncbi.nlm.nih.gov/pubmed/27246611 http://dx.doi.org/10.1186/s12967-016-0903-z |
Ejemplares similares
-
The P38α rs3804451 Variant Predicts Chemotherapy Response and Survival of Patients with Non–Small Cell Lung Cancer Treated with Platinum-Based Chemotherapy()
por: Jia, Ming, et al.
Publicado: (2016) -
Genetic variants of GADD45A, GADD45B and MAPK14 predict platinum-based chemotherapy-induced toxicities in Chinese patients with non-small cell lung cancer
por: Jia, Ming, et al.
Publicado: (2016) -
Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy
por: Zhang, Ruoxin, et al.
Publicado: (2017) -
Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma
por: Zhuge, Lingdun, et al.
Publicado: (2020) -
Comparative survival analysis of platinum‐based adjuvant chemotherapy for early‐stage squamous cell carcinoma and adenocarcinoma of the lung
por: Hsiao, Shih‐Hsin, et al.
Publicado: (2022)